Involvement of glucose and ATP-sensitive potassium (K+) channels on morphine-induced conditioned place preference

European Journal of Pharmacology

Volumn 573, Issue 1-3, 2007, Pages 133-138

  Zarrindast, Mohammad R ^a,b,c   Sattari Naeini, Manochehr ^d   Khalilzadeh, Azita ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^c INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

(Mice); ATP sensitive K+ channel; Conditioned place preference (CPP); Glucose; Morphine

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DIAZOXIDE; GLIBENCLAMIDE; GLUCOSE; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVERSION; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE TRANSPORT; LOCOMOTION; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PLACE AVERSION; PLACE PREFERENCE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REWARD;

ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DIAZOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLUCOSE; GLYBURIDE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; KATP CHANNELS; LOCOMOTION; MALE; MICE; MORPHINE; POTASSIUM CHANNEL BLOCKERS; REWARD; SPATIAL BEHAVIOR;

EID: 34648855444     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.044     Document Type: Article

References (43)

1. Amoroso S., Schmid-Antomarchi H., Fosset M., and Lazdunski M. Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels. Science 247 (1990) 852-854
2. Bardo M.T., Rowlett J.K., and Harris M.J. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci. Biobehav. Rev. 19 (1995) 39-51
3. Belzung C., and Barreau S. Differences in drug-induced place conditioning between BALB/c and C57Bl/6 mice. Pharmacol. Biochem. Behav. 65 (2000) 419-423
4. Calcagnetti D.J., and Schechter M.D. Conditioned place aversion following the central administration of a novel dopamine release inhibitor CGS 10746B. Pharmacol. Biochem. Behav. 40 (1991) 255-259
5. Cohen M.V., Yang X.M., Liu G.S., Heusch G., and Downey J.M. Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine, trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ. Res. 89 (2001) 273-278
6. Dunne M.J., Cosgrove K.E., Shepherd R.M., and Ammala C. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol. Metab. 10 (1999) 146-152
7. Durkin T.P., Messier C., de Boer P., and Westerink B.H. Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: an in vivo microdialysis study in the rat. Behav. Brain Res. 49 (1992) 181-188
8. Flint Jr. R.W., and Riccio D.C. Pretest administration of glucose attenuates infantile amnesia for passive avoidance conditioning in rats. Dev. Psychobiol. 31 (1997) 207-216
9. Ghelardini C., Galeotti N., and Bartolini A. Influence of potassium channel modulators on cognitive processes in mice. Br. J. Pharmacol. 123 (1998) 1079-1084
10. Gold P.E. Role of glucose in regulating the brain and cognition. Am. J. Clin. Nutr. 61 (1995) 987S-995S
11. Gonzalez L.G., Portillo E., Del Pozo E., and Baeyens J.M. Changes in [(3)H]glibenclamide binding to mouse forebrain membranes during morphine tolerance. Eur. J. Pharmacol. 418 (2001) 29-37
12. Hoffman D.C. The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res. Bull. 23 (1989) 373-387
13. Inan S.Y., Aksu F., and Baysal F. The effects of some K(+) channel blockers on scopolamine- or electroconvulsive shock-induced amnesia in mice. Eur. J. Pharmacol. 407 (2000) 159-164
14. Jafari M.R., Zarrindast M.R., and Djahanguiri B. Effects of different doses of glucose and insulin on morphine state-dependent memory of passive avoidance in mice. Psychopharmacology (Berl) 175 (2004) 457-462
15. Liang B.T., and Gross G.J. Direct preconditioning of cardiac myocytes via opioid receptors and KATP channels. Circ. Res. 84 (1999) 1396-1400
16. Lu L., Zeng S., Liu D., and Ceng X. Inhibition of the amygdala and hippocampalcalcium/calmodulin-dependent protein kinase II attenuates the dependence and relapse to morphine differently in rats. Neurosci. Lett. 291 (2000) 191-195
17. McNay E.C., and Gold P.E. Memory modulation across neural systems: intra-amygdala glucose reverses deficits caused by intraseptal morphine on a spatial task but not on an aversive task. J. Neurosci. 18 (1998) 3853-3858
18. Ocana M., and Baeyens J.M. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists. Br. J. Pharmacol. 110 (1993) 1049-1054
19. Ocana M., Del Pozo E., Barrios M., Robles L.I., and Baeyens J.M. An ATPdependent potassium channel blocker antagonizes morphine analgesia. Eur. J. Pharmacol. 186 (1990) 377-378
20. Ocana M., Del Pozo E., Barrios M., and Baeyens J.M. Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs. Br. J. Pharmacol. 114 (1995) 1296-1302
21. Ocana M., Barrios M., and Baeyens J.M. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors. J. Pharmacol. Exp. Ther. 276 (1996) 1136-1142
22. Olmstead M.C., and Franklin K.B. The development of a conditioned place preference to morphine: effects of microinjections into various CNS sites. Behav. Neurosci. 111 (1997) 1324-1334
23. Panten U., Schwanstecher M., and Schwanstecher C. Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol. Diabetes 104 (1996) 1-9
24. Parker L.A., and McDonald R.V. Reinstatement of both a conditioned place preference and a conditioned place aversion with drug primes. Pharmacol. Biochem. Behav. 66 (2000) 559-561
25. Parkes M., and White K.G. Glucose attenuation of memory impairments. Behav. Neurosci. 114 (2000) 307-319
26. Poggioli R., Benelli A., Arletti R., Cavazzuti E., and Bertolini A. K+ channel openers delay intestinal transit and have antidiarrheal activity. Eur. J. Pharmacol. 287 (1995) 207-209
27. Ragozzino M.E., Pal S.N., Unick K., Stefani M.R., and Gold P.E. Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections. J. Neurosci. 18 (1998) 1595-1601
28. Rashidy-Pour A. ATP-sensitive potassium channels mediate the effects of a peripheral injection of glucose on memory storage in an inhibitory avoidance task. Behav. Brain Res. 126 (2001) 43-48
29. Rezayof A., Golhasani-Keshtan F., Haeri-Rohani A., and Zarrindast M.R. morphine-induced place preference: Involvement of the central amygdala NMDA receptors. Brain Res 1133 (2007) 34-41
30. Rezayof A., Razavi S., Haeri-Rohani A., Rassouli Y., and Zarrindast M.R. GABA(A) receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference. Eur. Neuropsychopharmacol. 17 (2007) 24-31
31. Rodriguez De Fonseca F., Rubio P., Martin-Calderon J.L., Caine S.B., Koob G.F., and Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274 (1995) 47-55
32. Seino S., Iwanaga T., Nagashima K., and Miki T. Diverse roles of K(ATP) channels learned from Kir6.2 genetically engineered mice. Diabetes 49 (2000) 311-318
33. Shippenberg T.S., and Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Eur. J. Pharmacol. 151 (1988) 233-242
34. Stone W.S., Walser B., Gold S.D., and Gold P.E. Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists. Behav. Neurosci. 105 (1991) 264-271
35. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
36. Vergoni A.V., Scarano A., and Bertolini A. Pinacidil potentiates morphine analgesia. Life Sci. 50 (1992) PL135-PL138
37. White N.M. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91 (1996) 921-949
38. Wild K.D., Vanderah T., Mosberg H.I., and Porreca F. Opioid delta receptor subtypes are associated with different potassium channels. Eur. J. Pharmacol. 193 (1991) 135-136
39. Zarrindast M.R., Ahmadi S., Haeri-Rohani A., Rezayof A., Jafari M.R., and Jafari-Sabet M. GABA(A) receptors in the basolateral amygdala are involved in mediating morphine reward. Brain Res. 1006 (2004) 49-58
40. Zarrindast M.R., Jafari M.R., Ahmadi S., and Djahanguiri B. Influence of central administration ATP-dependent K+ channel on morphine state-dependent memory of passive avoidance. Eur. J. Pharmacol. 487 (2004) 143-148
41. Zarrindast M.R., Jafari M.R., Shafaghi B., and Djahanguiri B. Influence of potassium channel modulators on morphine state-dependent memory of passive avoidance. Behav. Pharmacol. 15 (2004) 103-110
42. Zarrindast M.R., Karami M., Sepehri H., and Sahraei H. Influence of nitric oxide on morphine-induced conditioned place preference in the rat central amygdala. Eur. J. Pharmacol. 453 (2002) 81-89
43. Zarrindast M.R., Rezayof A., Sahraei H., Haeri-Rohani A., and Rassouli Y. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res. 965 (2003) 212-221